相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of CD155/TIGIT expression in patients with colorectal cancer
Daisuke Murakami et al.
PLOS ONE (2022)
Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
Alhasan Alsalman et al.
CANCERS (2022)
The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
Jin-Ling Huo et al.
FRONTIERS IN IMMUNOLOGY (2022)
Upregulation of TIGIT and PD-1 in Colorectal Cancer with Mismatch-repair Deficiency
Xuebing Zhou et al.
IMMUNOLOGICAL INVESTIGATIONS (2021)
Transcriptome Profiling Identifies TIGIT as a Marker of T-Cell Exhaustion in Liver Cancer
Dmitrij Ostroumov et al.
HEPATOLOGY (2021)
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
Salman M. Toor et al.
VACCINES (2021)
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer
Sara S. F. Al-Badran et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis
Kunmin Xiao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
Peipei Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
Nuttavut Sumransub et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow
Ling Xu et al.
FRONTIERS IN ONCOLOGY (2021)
Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
Yujun Park et al.
ONCOIMMUNOLOGY (2021)
Immunotherapy in Colorectal Cancer: Current and Future Strategies
Akira Ooki et al.
JOURNAL OF THE ANUS RECTUM AND COLON (2021)
Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients
Kunpeng Lv et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
Gregory E. Idos et al.
SCIENTIFIC REPORTS (2020)
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
Mara Kitsou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
Yaping Wang et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Differential expression of TIM-3 in circulation and tumor microenvironment of colorectal cancer patients
Sarah Khalaf et al.
CLINICAL IMMUNOLOGY (2020)
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Anqi Lin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis
Mengzhou Guo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
TIGIT in cancer immunotherapy
Joe-Marc Chauvin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Quantitative and functional characteristics of circulating and bone marrow PD-1-and TIM-3-positive T cells in treated multiple myeloma patients
Egor Batorov et al.
SCIENTIFIC REPORTS (2020)
Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes
Woo Jin Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova et al.
CLINICAL CANCER RESEARCH (2019)
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer
Sumana Narayanan et al.
SCIENTIFIC REPORTS (2019)
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
Salman M. Toor et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunology Behind Tumors: A Mini Review
Pooja Hurkat et al.
CURRENT CANCER THERAPY REVIEWS (2019)
TIGIT immune checkpoint blockade restores CD8(+) T-cell immunity against multiple myeloma
Camille Guillerey et al.
BLOOD (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi et al.
CANCER CELL (2018)
CD8+ T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients
Mengjie Wang et al.
CLINICAL IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer
Xiang Hu et al.
EBIOMEDICINE (2018)
T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer
Kyung Do Byun et al.
JOURNAL OF BREAST CANCER (2018)
Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
Muming Yu et al.
MOLECULAR MEDICINE REPORTS (2017)
Down-regulated expression of Tim-3 promotes invasion and metastasis of colorectal cancer cells
Q. Y. Sun et al.
NEOPLASMA (2017)
Association of LAG-3 expression in tumor infiltrating immune cells with prognosis in patients with microsatellite instability high colon cancer.
Soo Jung Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (vol 15, pg 857, 2016)
Marios Giannakis et al.
CELL REPORTS (2016)
Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2015)
Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
Liyun Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The Upregulation of LAG-3 on T Cells Defines a Subpopulation with Functional Exhaustion and Correlates with Disease Progression in HIV-Infected Subjects
Xiaoling Tian et al.
JOURNAL OF IMMUNOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
Z. Mei et al.
BRITISH JOURNAL OF CANCER (2014)
The effect of immune microenvironment on the progression and prognosis of colorectal cancer
Jinxiang Chen et al.
MEDICAL ONCOLOGY (2014)
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Leukocyte composition of human breast cancer
Brian Ruffell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Junko Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells
Yu Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
分享论文
